Sihuan Pharmaceutical Holdings Group Ltd

HK$0.745-HK$0.01 (1.32%)

Estimate

Beta

0.877

Growth

Revenue, YoY

22.27%

Net income, YoY

772.28%

Forecast

P/E (FWD)

5.3

EPS (FWD)

0.14

Dividends

Dividend yield

1.46%

Annual payout

HK$0.01

Next ex. div date

June 30, 27

Payout

101.7%

Div.growth, 5y

-40.78%

Div.rating

About the company

Ticker

0460

ISIN

BMG8162K1137

Country

Hong Kong

Sector (GICS)

Healthcare

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invasive comprehensive medical aesthetics solutions. It also provides drugs for cardio-cerebral vascular, digestive system, anti-infective, metabolism, respiratory, neurology, oncology, diabetes, and other indications, as well as modern Chinese medicine and industrial hemp products. In addition, the company offers general hospital services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.

Frequently asked questions

What sector does Sihuan Pharmaceutical Holdings Group Ltd (0460) operate in?

Sihuan Pharmaceutical Holdings Group Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Sihuan Pharmaceutical Holdings Group Ltd (0460) current stock price?

As of the latest data, Sihuan Pharmaceutical Holdings Group Ltd stock price is HK$0.75, with a previous close of HK$0.76. Sihuan Pharmaceutical Holdings Group Ltd lost -HK$0.01 in the last trading session, representing a -1.32% loss.

What is Sihuan Pharmaceutical Holdings Group Ltd (0460) current market capitalization?

Sihuan Pharmaceutical Holdings Group Ltd market cap is approximately 6.79 billion.

What is Sihuan Pharmaceutical Holdings Group Ltd (0460) EBITDA?

Sihuan Pharmaceutical Holdings Group Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 298.31 million.

Does Sihuan Pharmaceutical Holdings Group Ltd (0460) pay dividends?

Yes. Sihuan Pharmaceutical Holdings Group Ltd pays annual dividends with an annualized yield of 1.46% and an estimated annual payout of HK$0.01 per share.

When is the next ex-dividend date for Sihuan Pharmaceutical Holdings Group Ltd (0460)?

The next ex-dividend date is scheduled for June 30, 2027.

When is Sihuan Pharmaceutical Holdings Group Ltd (0460) next earnings report?

Sihuan Pharmaceutical Holdings Group Ltd is expected to release its next earnings report on June 30, 2026.

What is Sihuan Pharmaceutical Holdings Group Ltd (0460) beta (volatility) score?

Sihuan Pharmaceutical Holdings Group Ltd has a beta of 0.877, meaning its volatility is roughly in line with the market.